Description

n-{[(1S,5R)-8-Oxo-1,5,6,8-Tetrahydro-2H-1,5-Methano-Pyrido[1,2-A][1,5]Diazocin-3(4H)-Yl]Carbonyl} is a high-purity, advanced pharmaceutical intermediate characterized by its complex, polycyclic diazocine structure. This compound is of significant value for its role as a key building block in the synthesis of novel, potent active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly within the fields of oncology and central nervous system (CNS) disorders.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of complex drug candidates, especially those targeting specific biological pathways.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new chemical entities with improved efficacy and safety profiles.
• Process Chemistry Development: Serves as a key starting material (KSM) or intermediate in scaling up synthetic routes from laboratory to pilot plant and commercial production.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and development services for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for studying novel heterocyclic chemistry and developing new synthetic methodologies.
• Bioconjugation & Probe Development: Potential use in creating labeled compounds or probes for biochemical and pharmacological assays due to its functionalizable carbonyl group.

Basic Information

Product Name	n-{[(1S,5R)-8-Oxo-1,5,6,8-Tetrahydro-2H-1,5-Methano-Pyrido[1,2-A][1,5]Diazocin-3(4H)-Yl]Carbonyl}
CAS No.	956923-67-4
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	(1S,5R)-3-[(Aminocarbonyl)-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one; 8-Oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocine-3-carboxamide; n-[(8-Oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocin-3-yl)]carbonyl; 956923-67-4; 1,5-Methano-pyrido[1,2-a][1,5]diazocine-3-carboxamide, 1,5,6,8-tetrahydro-8-oxo-, (1S,5R)-; (1S,5R)-1,5,6,8-Tetrahydro-8-oxo-1,5-methanopyrido[1,2-a][1,5]diazocine-3-carboxamide
EINECS	Contact for details

Quality Control

Our n-{[(1S,5R)-8-Oxo-1,5,6,8-Tetrahydro-2H-1,5-Methano-Pyrido[1,2-A][1,5]Diazocin-3(4H)-Yl]Carbonyl} is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and cGMP applications. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and other critical parameters is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.